ReviewTherapeutic advances in medical oncology2025

The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond.

Alice Bernard-Tessier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.